Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Precision Cell Immunotherapy”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07653451
What this trial is testing

Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 90
Testing effectiveness (Phase 2)UnknownNCT02862561
What this trial is testing

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Precision Cell ImmunotherapyChemotherapyAdvanced Malignancies
Shanghai International Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05469893
What this trial is testing

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
High-risk Smoldering Multiple MyelomaSmoldering Multiple MyelomaMultiple Myeloma
Irene Ghobrial, MD 52
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)UnknownNCT02873442
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision Cell ImmunotherapyTranscatheter Arterial ChemoembolizationAdvanced Liver Cancer
Ningbo Cancer Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05767359
What this trial is testing

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT02873416
What this trial is testing

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Who this might be right for
Precision Cell ImmunotherapyChemotherapyAdvanced Lung Cancer
Ningbo Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02862613
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision CellsTranscatheter Arterial ChemoembolizationAdvanced Liver Cancer
Shanghai International Medical Center 40
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Testing effectiveness (Phase 2)Looking for participantsNCT02559778
What this trial is testing

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Who this might be right for
Neuroblastoma
Giselle Sholler 500
Testing effectiveness (Phase 2)UnknownNCT02862587
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision CellsChemotherapyAdvanced Lung Cancer
Shanghai International Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02632201
What this trial is testing

Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis

Who this might be right for
Liver MetastasisGastric Cancer
Second Military Medical University 40
Early research (Phase 1)Not Yet RecruitingNCT07695311
What this trial is testing

EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

Who this might be right for
Ewing SarcomaDesmoplastic Small Round Cell Tumor
Rabi Hanna 24
Testing effectiveness (Phase 2)UnknownNCT02632188
What this trial is testing

Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Second Military Medical University 60
Not applicableNot Yet RecruitingNCT06922266
What this trial is testing

Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ospedale San Raffaele 20
Testing effectiveness (Phase 2)UnknownNCT03658785
What this trial is testing

Immunotherapy for the Treatment of Advanced Solid Tumor

Who this might be right for
Recurrence TumorMetastatic CancerSolid Tumor
Tongji Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02632019
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract

Who this might be right for
Advanced Biliary Tract Malignant Tumor
Second Military Medical University 40
Testing effectiveness (Phase 2)UnknownNCT02873520
What this trial is testing

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Precision Cell ImmunotherapyChemotherapyAdvanced Gastric Cancer
Ningbo Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02632006
What this trial is testing

Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Second Military Medical University 40
Next Page